论文部分内容阅读
目的分析甘精胰岛素与二甲双胍用于治疗2型糖尿病的临床效果。方法 100例2型糖尿病患者,随机分为观察组与对照组,各50例。对照组给予二甲双胍治疗,观察组给予甘精胰岛素与二甲双胍治疗,观察两组患者的各项血糖指标以及低血糖发生率。结果治疗后观察组各项血糖指标情况均明显优于对照组(P<0.05);观察组治疗后的低血糖发生率明显低于对照组,差异有统计学意义(P<0.05)。结论甘精胰岛素与二甲双胍用于治疗2型糖尿病疗效显著,具有低血糖发生率低及安全性高的优势,值得临床推广。
Objective To analyze the clinical effects of insulin glargine and metformin in the treatment of type 2 diabetes mellitus. Methods 100 cases of type 2 diabetes were randomly divided into observation group and control group, 50 cases each. The control group was treated with metformin. The observation group was treated with insulin glargine and metformin. The blood sugar and the incidence of hypoglycemia in both groups were observed. Results After treatment, all the indexes of blood glucose in the observation group were significantly better than those in the control group (P <0.05). The incidence of hypoglycemia in the observation group was significantly lower than that in the control group (P <0.05). Conclusion Glargine and metformin are effective in treating type 2 diabetes with low hypoglycemia incidence and high safety. It is worthy of clinical promotion.